Success Metrics

Completion Rate
0%(0/1)
Active Trials
0(0%)
Terminated
1(20%)

Phase Distribution

Ph early_phase_1
1
20%
Ph phase_3
1
20%
Ph phase_2
2
40%
Ph phase_4
1
20%

Phase Distribution

1

Early Stage

2

Mid Stage

2

Late Stage

Phase Distribution5 total trials
Early Phase 1First-in-human
1(20.0%)
Phase 2Efficacy & side effects
2(40.0%)
Phase 3Large-scale testing
1(20.0%)
Phase 4Post-market surveillance
1(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Active(2)
Terminated(1)
Other(2)

Detailed Status

Not yet recruiting2
unknown1
Suspended1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
0.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (20.0%)
Phase 22 (40.0%)
Phase 31 (20.0%)
Phase 41 (20.0%)

Trials by Status

unknown120%
not_yet_recruiting240%
suspended120%
terminated120%

Recent Activity

Clinical Trials (5)

Drug Details

Intervention Type
DRUG
Total Trials
5